Skip to content

Dr. Lore Leempoels

Active
Private limited companyfounded 2018active for 7 yearsDomeinstraat 51, 3010 Leuven, BelgiumKBO/BCE: BE 0715.609.085

From the official registers: KBO 8 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Lore Leempoels has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €100 and a net result of €105,513. Equity has been shrinking by about 41% per year since 2018. Its solvency ranks better than 5% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 07-12-2018 Normal situation
Activity
Specialist medical practice NACE 86220and 2 others
Establishment unit
2.282.702.384 3010 Leuven, since 07-12-2018
Financial year end
31 December
Peppol
Reachable since 27-10-2025

Board and ownership

Board
  • Leempoels LoreDirector

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€170,794
▲ 54.6%
Turnover
≈ €320,000
estimated
Profit
€105,513
▲ 54.7%
Equity
€100
▼ 99.5%
Total assets
€356,512
▲ 5.4%
Filed on 18-03-2026, 135 days before the deadlinePDF
Score breakdownraises riskEquity €100 (0.0% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €356,512Liquidity: current ratio 0.79, cash €105,448Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 34% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 25-6
equity 0.0% of total assets
Liquidity 69-10
short-term debt 38.0% · cash 29.6%
Profitability 100+6
return on assets 29.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025highest value 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 4% of them on solvency, 50% on liquidity, 80% on profitability and 2% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €356,512
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €100 (0.0% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.79, cash €105,448
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-03-2026, 135 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
135 days early
2024
84 days early
2023
90 days early
2022
34 days early
2021
31 days early
2020
29 days early
2019
49 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 65 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 May (4 of the last 5 accounts filed within 51 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 95% of companies in human healthsector median 63.0% · 20,678 companies 0.0% View
  • Positive: 8 profitable years in a rowprofit 2025: €105,513 8 years View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View

Comparable companies

These companies have the same main activity as Dr. Lore Leempoels: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €340,000 and €399,000, founded between 2018 and 2019.

CompanyTotal assetsGross margin
Dr. Lore Leempoels Leuven€356,512€170,794
Dokter Singh skb psychiatrie Rotselaar€352,470€173,698
Dokter E Rossou Boortmeerbeek€348,373€164,587
Dr. C. Kesteloot Grimbergen€364,478€179,596
DR. VOLCKAERT KARLIEN, FYSISCHE GENEESKUNDE Dilbeek€399,456€170,202
DR JANSSEN CHRISTOPHE Braine-le-Comte€368,084€182,156
DR. GREET ROEF ENDOCRINOLOGIE Deinze€340,131€162,843
Full comparison

Documents

Annual accounts at the NBB

All 8 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. Lore Leempoels

What is the company number of Dr. Lore Leempoels?
The company number of Dr. Lore Leempoels is 0715.609.085. The VAT number is the same number with BE in front: BE 0715.609.085.
Where is Dr. Lore Leempoels based?
The registered office is at Domeinstraat 51, 3010 Leuven.Company details
What does Dr. Lore Leempoels do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Lore Leempoels?
The legal form of Dr. Lore Leempoels is Private limited company (BV).
When was Dr. Lore Leempoels founded?
Dr. Lore Leempoels was founded on 07-12-2018.
Is Dr. Lore Leempoels still active?
Yes, Dr. Lore Leempoels is an active enterprise in the KBO register.
What is the turnover of Dr. Lore Leempoels?
The turnover in financial year 2025 is ≈ €320,000. This figure is estimated from the gross margin of €170,794 and 43 comparable companies (NACE 86220). It probably lies between €270,000 and €420,000. In financial year 2021 turnover was €143,028.Financials
Is Dr. Lore Leempoels profitable?
In financial year 2025, Dr. Lore Leempoels made a profit of €105,513.
Where can I find the annual accounts of Dr. Lore Leempoels?
Dr. Lore Leempoels filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Dr. Lore Leempoels due?
Dr. Lore Leempoels must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.